Nuclear expression of the non–B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma
2007; Elsevier BV; Volume: 111; Issue: 2 Linguagem: Inglês
10.1182/blood-2007-06-093401
ISSN1528-0020
AutoresSara Ek, Michael Dictor, Mats Jerkeman, Karin Jirström, Carl Borrebaeck,
Tópico(s)Ubiquitin and proteasome pathways
ResumoMantle cell lymphoma (MCL) is defined pathologically by the detection of CD20, CD5, and most importantly cyclin D1 (CCND1). Its distinction from other lymphomas is important for prognosis and appropriate therapy, but occasional cases may fail to express CCND1 and morphologic simulators may express CD20 and CD5 but not CD23. In this study, we show that the transcription factor Sox11 is specifically expressed in the nucleus of MCL compared with other lymphomas and benign lymphoid tissue. Although the role of Sox11 presently is not known in lymphocyte ontogeny, it is normally expressed in the developing central nervous system in the embryo and shows sequence homology with Sox4, a transcription factor crucial for B lymphopoiesis. Sox11 mRNA is increased in gliomas compared with healthy brain tissue, suggesting a role in malignant transformation and/or cell survival. Our novel finding of specific overexpression of Sox11 mRNA and nuclear protein in both cyclin D1–positive and – negative MCL may be useful for the diagnosis of MCL as a complement to cyclin D1 and also suggests a functional role for Sox11 in MCL.
Referência(s)